Plain-English translation of NCT04769362 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether people who have recovered from a heart attack can safely stop taking beta-blockers after at least one year of treatment. Beta-blockers are medications that protect your heart by reducing stress on it and helping prevent dangerous heart rhythms. The study will compare two groups: people who stop the medication and people who keep taking it, to see if both groups do equally well.
Doctors currently recommend that all heart attack patients take this medication long-term, but no one is certain how long people really need to take it if their heart is functioning normally. This study will help doctors decide whether patients can safely stop the medication after a year or whether continuing it is more protective.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either stop taking the medication or continue taking it. You'll have regular follow-up visits where your doctors will monitor your heart health and check how you're doing. The study will track you for several years to see which group has better outcomes.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
South Korea